• Je něco špatně v tomto záznamu ?

2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work

A. Boonen, C. Webers, M. Butink, B. Barten, N. Betteridge, DC. Black, A. Bremander, B. Boteva, O. Brzezińska, L. Chauhan, S. Copsey, V. Guimarães, M. Gignac, J. Glaysher, F. Green, JL. Hoving, ML. Marques, H. Smucrova, TA. Stamm, D. Wiek, R....

. 2023 ; 82 (1) : 57-64. [pub] 20220915

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004814

Grantová podpora
21755 Versus Arthritis - United Kingdom

E-zdroje Online Plný text

NLK ProQuest Central od 1939-01-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest) od 1939-01-01 do Před 6 měsíci

AIM: As part of its strategic objectives for 2023, EULAR aims to improve the work participation of people with rheumatic and musculoskeletal diseases (RMDs). One strategic initiative focused on the development of overarching points to consider (PtC) to support people with RMDs in healthy and sustainable paid work participation. METHODS: EULAR's standardised operating procedures were followed. A steering group identified six research areas on paid work participation. Three systematic literature reviews, several non-systematic reviews and two surveys were conducted. A multidisciplinary taskforce of 25 experts from 10 European countries and Canada formulated overarching principles and PtC after discussion of the results of literature reviews and surveys. Consensus was obtained through voting, with levels of agreement obtained anonymously. RESULTS: Three overarching principles and 11 PtC were formulated. The PtC recognise various stakeholders are important to improving work participation. Five PtC emphasise shared responsibilities (eg, obligation to provide active support) (PtC 1, 2, 3, 5, 6). One encourages people with RMDs to discuss work limitations when necessary at each phase of their working life (PtC 4) and two focus on the role of interventions by healthcare providers or employers (PtC 7, 8). Employers are encouraged to create inclusive and flexible workplaces (PtC 10) and policymakers to make necessary changes in social and labour policies (PtC 9, 11). A research agenda highlights the necessity for stronger evidence aimed at personalising work-related support to the diverse needs of people with RMDs. CONCLUSION: Implementation of these EULAR PtC will improve healthy and sustainable work participation of people with RMDs.

Bone and Joint Research Group Royal Cornwall Hospital Truro UK

British Airways London UK

Bulgarian Organisation for People with Rheumatic Diseases Sofia Bulgaria

Care and Public Health Research Institute Maastricht University Maastricht The Netherlands

Centre for Ageing Better London UK

Centre for Epidemiology Versus Arthritis Centre for Musculoskeletal Research Faculty of Biology Medicine and Health The University of Manchester Manchester UK

Dalla Lana School for Public Health University of Toronto Toronto Ontario Canada

Department of Clinical Sciences Lund University Lund Sweden

Department of Public and Occupational Health Amsterdam Public Health Research Institute Amsterdam The Netherlands

Department of Regional Health Research University of Southern Denmark Odense Denmark

Department of Rheumatology and Clinical Immunology University Medical Center Utrecht Utrecht The Netherlands

Department of Rheumatology Leiden University Medical Center Leiden The Netherlands

Department of Rheumatology Medical University of Lodz Lodz Poland

EULAR Research Partner EULAR PARE Zurich Switzerland

European Agency for Safety and Health at Work Bilbao Spain

Hekla Communications Brussels Belgium

Independent Adviser to the UK Government on Combatting Drugs Misuse London UK

Institute for Work and Health Toronto Ontario Canada

Institute of Rheumatology Prague Czech Republic

Internal Medicine Division of Rheumatology Maastricht University Medical Centre Maastricht The Netherlands

John Lewis Partnership London UK

Liga Portuguesa Contra as Doenças Reumáticas Lisbon Portugal

MRC Versus Arthritis Centre for Musculoskeletal Health and Work University of Southampton Southhampton UK

Neil Betteridge Associates London UK

NIHR Manchester Biomedical Research Centre Manchester University NHS Foundation Trust Manchester Academic Health Center Manchester UK

Primary Care Centre Versus Arthritis School of Medicine Keele University Staffordshire UK

Rheumatology and Clinical Immunology Charité Universitätsmedizin Berlin Berlin Germany

Rheumatology Centro Hospitalar e Universitario de Coimbra EPE Coimbra Portugal

Section for Outcomes Research Medical University of Vienna Vienna Austria

Social Medicine Maastricht University Maastricht The Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004814
003      
CZ-PrNML
005      
20230425171732.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ard-2022-222678 $2 doi
035    __
$a (PubMed)36109139
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Boonen, Annelies $u Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands a.boonen@mumc.nl $u Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, The Netherlands $1 https://orcid.org/0000000306829533
245    10
$a 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work / $c A. Boonen, C. Webers, M. Butink, B. Barten, N. Betteridge, DC. Black, A. Bremander, B. Boteva, O. Brzezińska, L. Chauhan, S. Copsey, V. Guimarães, M. Gignac, J. Glaysher, F. Green, JL. Hoving, ML. Marques, H. Smucrova, TA. Stamm, D. Wiek, R. Wilkie, AD. Woolf, GR. Burmester, JW. Bijlsma, SMM. Verstappen
520    9_
$a AIM: As part of its strategic objectives for 2023, EULAR aims to improve the work participation of people with rheumatic and musculoskeletal diseases (RMDs). One strategic initiative focused on the development of overarching points to consider (PtC) to support people with RMDs in healthy and sustainable paid work participation. METHODS: EULAR's standardised operating procedures were followed. A steering group identified six research areas on paid work participation. Three systematic literature reviews, several non-systematic reviews and two surveys were conducted. A multidisciplinary taskforce of 25 experts from 10 European countries and Canada formulated overarching principles and PtC after discussion of the results of literature reviews and surveys. Consensus was obtained through voting, with levels of agreement obtained anonymously. RESULTS: Three overarching principles and 11 PtC were formulated. The PtC recognise various stakeholders are important to improving work participation. Five PtC emphasise shared responsibilities (eg, obligation to provide active support) (PtC 1, 2, 3, 5, 6). One encourages people with RMDs to discuss work limitations when necessary at each phase of their working life (PtC 4) and two focus on the role of interventions by healthcare providers or employers (PtC 7, 8). Employers are encouraged to create inclusive and flexible workplaces (PtC 10) and policymakers to make necessary changes in social and labour policies (PtC 9, 11). A research agenda highlights the necessity for stronger evidence aimed at personalising work-related support to the diverse needs of people with RMDs. CONCLUSION: Implementation of these EULAR PtC will improve healthy and sustainable work participation of people with RMDs.
650    _2
$a lidé $7 D006801
650    12
$a revmatické nemoci $x terapie $7 D012216
650    12
$a muskuloskeletální nemoci $x terapie $7 D009140
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a konsensus $7 D032921
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Webers, Casper $u Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands $u Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, The Netherlands $1 https://orcid.org/0000000330118547
700    1_
$a Butink, Maarten $u Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands $u Social Medicine, Maastricht University, Maastricht, The Netherlands $1 https://orcid.org/0000000259999782
700    1_
$a Barten, Birgit $u EULAR Research Partner, EULAR PARE, Zurich, Switzerland
700    1_
$a Betteridge, Neil $u Neil Betteridge Associates, London, UK
700    1_
$a Black, Dame Carol $u Centre for Ageing Better, London, UK $u Independent Adviser to the UK Government on Combatting Drugs Misuse, London, UK
700    1_
$a Bremander, Ann $u Department of Regional Health Research, University of Southern Denmark, Odense, Denmark $u Department of Clinical Sciences, Lund University, Lund, Sweden
700    1_
$a Boteva, Boryana $u EULAR Research Partner, EULAR PARE, Zurich, Switzerland $u Bulgarian Organisation for People with Rheumatic Diseases (BOPRD), Sofia, Bulgaria
700    1_
$a Brzezińska, Olga $u Department of Rheumatology, Medical University of Lodz, Lodz, Poland $1 https://orcid.org/0000000238858497
700    1_
$a Chauhan, Lina $u British Airways, London, UK
700    1_
$a Copsey, Sarah $u European Agency for Safety and Health at Work (EU-OSHA), Bilbao, Spain
700    1_
$a Guimarães, Vera $u Liga Portuguesa Contra as Doenças Reumáticas, Lisbon, Portugal
700    1_
$a Gignac, Monique $u Institute for Work & Health, Toronto, Ontario, Canada $u Dalla Lana School for Public Health, University of Toronto, Toronto, Ontario, Canada
700    1_
$a Glaysher, Jennifer $u John Lewis Partnership, London, UK
700    1_
$a Green, Frans $u Hekla Communications, Brussels, Belgium
700    1_
$a Hoving, Jan L $u Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
700    1_
$a Marques, Mary Lucy $u Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands $u Rheumatology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal
700    1_
$a Smucrova, Hana $u Institute of Rheumatology, Prague, Czech Republic $1 https://orcid.org/0000000186144934
700    1_
$a Stamm, Tanja A $u Section for Outcomes Research, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000330737284
700    1_
$a Wiek, Dieter $u EULAR Research Partner, EULAR PARE, Zurich, Switzerland
700    1_
$a Wilkie, Ross $u Primary Care Centre Versus Arthritis, School of Medicine - Keele University, Staffordshire, UK $1 https://orcid.org/000000034825714X
700    1_
$a Woolf, Anthony D $u Bone and Joint Research Group, Royal Cornwall Hospital, Truro, UK
700    1_
$a Burmester, Gerd R $u Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany $1 https://orcid.org/0000000175181131
700    1_
$a Bijlsma, Johannes W $u Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands $1 https://orcid.org/0000000201288451
700    1_
$a Verstappen, Suzanne M M $u Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research - Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u NIHR Manchester Biomedical Research Centre - Manchester University NHS Foundation Trust, Manchester Academic Health Center, Manchester, UK $u MRC Versus Arthritis Centre for Musculoskeletal Health and Work, University of Southampton, Southhampton, UK
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 82, č. 1 (2023), s. 57-64
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36109139 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171729 $b ABA008
999    __
$a ok $b bmc $g 1925104 $s 1191023
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 82 $c 1 $d 57-64 $e 20220915 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
GRA    __
$a 21755 $p Versus Arthritis $2 United Kingdom
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...